Literature DB >> 32522634

Bipolar Radiofrequency Ablation on Explanted Human Hearts: How to Ensure Transmural Lesions.

Ali J Khiabani1, Robert M MacGregor1, Joshua L Manghelli1, Chawannuch Ruaengsri1, Daniel I Carter1, Spencer J Melby1, Richard B Schuessler1, Ralph J Damiano2.   

Abstract

BACKGROUND: Bipolar radiofrequency (RF) clamps have been shown to be capable of reproducibly creating transmural lesions with a single ablation in animal models. Unfortunately in clinical experience the bipolar clamps have not been as effective and often require multiple ablations to create conduction block. This study created a new experimental model using fresh, cardioplegically arrested human hearts turned down for transplant to evaluate the performance of a nonirrigated bipolar RF clamp.
METHODS: Nine human hearts turned down for transplant were harvested, and the Cox-Maze IV lesion set was performed with a nonirrigated bipolar RF clamp. In the first 7 hearts a single ablation was performed for each lesion. In the last 2 hearts a set of 2 successive ablations without unclamping were performed. The heart tissue was stained with 2,3,5-triphenyl-tetrazolium chloride. Each ablation lesion was cross-sectioned to assess lesion depth and transmurality.
RESULTS: A single ablation with the bipolar RF clamp resulted in 89% (469/529) of the histologic sections and 65% (42/65) of the lesions being transmural. Of the nontransmural sections, 92% occurred in areas with epicardial fat. Performing 2 successive ablations without unclamping resulted in 100% of the cross-sections (201/201) and lesions (25/25) being transmural.
CONCLUSIONS: A single ablation failed to create a transmural lesion 35% of the time, and this was associated with the presence of epicardial fat. Two successive ablations without unclamping resulted in 100% lesion transmurality using the bipolar RF clamp.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32522634      PMCID: PMC7669627          DOI: 10.1016/j.athoracsur.2020.04.079

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

Review 1.  The development of the Maze procedure for the treatment of atrial fibrillation.

Authors:  J L Cox; R B Schuessler; J P Boineau
Journal:  Semin Thorac Cardiovasc Surg       Date:  2000-01

2.  The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.

Authors:  Sunil M Prasad; Hersh S Maniar; Cindy J Camillo; Richard B Schuessler; John P Boineau; Thoralf M Sundt; James L Cox; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

3.  Thermal-electrical modeling for epicardial atrial radiofrequency ablation.

Authors:  Enrique J Berjano; Fernando Hornero
Journal:  IEEE Trans Biomed Eng       Date:  2004-08       Impact factor: 4.538

Review 4.  Ablation technology for the surgical treatment of atrial fibrillation.

Authors:  Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  ASAIO J       Date:  2013 Sep-Oct       Impact factor: 2.872

5.  Wide variations in energy delivery using an impedance-controlled algorithm in bipolar radiofrequency ablation: evidence against fixed time ablation.

Authors:  Spencer J Melby; Andreas Zierer; Rochus K Voeller; Shelly C Lall; Marci S Bailey; Marc R Moon; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2007-03

6.  Evaluation of a Novel Cryoprobe for Atrial Ablation in a Chronic Ovine Model.

Authors:  Matthew R Schill; Spencer J Melby; Molly Speltz; May Breitbach; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2017-09       Impact factor: 4.330

7.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

8.  Successful performance of Cox-Maze procedure on beating heart using bipolar radiofrequency ablation: a feasibility study in animals.

Authors:  Sydney L Gaynor; Yosuke Ishii; Michael D Diodato; Sunil M Prasad; Kara M Barnett; Nicholas R Damiano; Gregory D Byrd; Samuel A Wickline; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

9.  Epicardial Ablation on the Beating Heart: Limited Efficacy of a Novel, Cooled Radiofrequency Ablation Device.

Authors:  Anson M Lee; Abdulhameed Aziz; Shun-Ichiro Sakamoto; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2009

10.  Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study.

Authors:  Sunil M Prasad; Hersh S Maniar; Michael D Diodato; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

View more
  4 in total

Review 1.  A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent.

Authors:  Riyaz A Kaba; Omar Ahmed; Elijah Behr; Aziz Momin
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

2.  Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts.

Authors:  Johanna U Neuber; Andrei G Pakhomov; Christian W Zemlin
Journal:  PLoS One       Date:  2021-09-24       Impact factor: 3.240

3.  Mid-term outcomes of concomitant Cox-Maze IV: Results from a multicenter prospective registry.

Authors:  Marc Gerdisch; Eric Lehr; Gansevoort Dunnington; John Johnkoski; Andrew Barksdale; Manesh Parikshak; Patrick Ryan; Samuel Youssef; Robert Fletcher; Glenn Barnhart
Journal:  J Card Surg       Date:  2022-07-23       Impact factor: 1.778

4.  In vivo preliminary test of a new biparietal bidirectional bipolar radiofrequency magnetic coupling system.

Authors:  Francesco Matteucci; Mark La Meir; Bart Maesen; Gian-Battista Chierchia; Carlo De Asmundis; Sandro Gelsomino
Journal:  Pacing Clin Electrophysiol       Date:  2021-08-02       Impact factor: 1.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.